Vascular endothelial cell macromolecules in lesion microvasculature

Vascular endothelial cell macromolecules in lesion microvasculature refers to a heterogeneous group of proteins, glycoproteins, and glycolipids that are selectively expressed or upregulated on the luminal surface of endothelial cells within diseased tissues. These molecules, often termed vascular zip codes, are characteristic of the activated or angiogenic endothelium found in tumors, chronic inflammatory sites, and atherosclerotic plaques, while remaining largely absent or quiescent in healthy tissues (Ruoslahti, 2004, Biochem Soc Trans). Key examples include Vascular Endothelial Growth Factor Receptors (VEGFRs), integrins like alpha-v beta-3, aminopeptidase N (CD13), and endoglin (Muzykantov, 2005, Int J Pharm). These macromolecules are primary targets for vascular targeting agents (VTAs) and vascular disrupting agents (VDAs), which aim to either prevent the growth of new blood vessels or selectively destroy the existing lesion-associated vasculature (Thorpe, 2004, Clin Cancer Res). Because these targets are directly exposed to the circulating blood, they provide a highly accessible platform for the delivery of therapeutic payloads, including radionuclides, toxins, and nanocarriers. This approach enhances local drug concentration at the site of the lesion while minimizing systemic toxicity to healthy organs. Clinical success has been seen with agents like bevacizumab and ramucirumab, which interfere with the signaling pathways mediated by these surface-expressed receptors.

Other names

Vascular targeting markersTumor endothelial markersAngiogenic markersVascular zip codesEndothelial surface markersLesion-associated endothelial markers

Binding to surface-expressed endothelial proteins to inhibit angiogenic signaling, induce vascular collapse, or deliver targeted therapeutic agents.